Yoichi Kobayashi
Overview
Explore the profile of Yoichi Kobayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
189
Citations
1065
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Watanabe M, Kobayashi Y, Ishida M, Tajima A, Tanigaki S, Morisada T
Reprod Sci
. 2025 Feb;
32(3):702-715.
PMID: 39909972
Endometriosis and ovarian endometrioma (OMA) cause dysmenorrhea and infertility. Current hormonal therapies for OMA treatment, may exhibit limited effectiveness. Hormonal treatments function by downregulate estrogen receptors (ERs) via progesterone receptor...
2.
Kobayashi Y, Asai-Sato M, Kuji S, Sakai H, Yamaguchi K, Suzuki N, et al.
J Obstet Gynaecol Res
. 2025 Feb;
51(2):e16225.
PMID: 39908989
Aim: This study aimed to assess the awareness of the concept of "cardio-oncology" and cardiovascular disease (CVD) in patients with endometrial cancer (EC) among the Japanese Gynecologic Oncology Group members....
3.
Kimura M, Yoshioka D, Chang I, Irizawa A, Shibata D, Imada S, et al.
Angew Chem Int Ed Engl
. 2025 Jan;
:e202423776.
PMID: 39869399
Inorganic photochromic materials offer several advantages over organic compounds, including relatively inexpensive and higher thermal stability. However, tuning their color with the same component has remained a significant challenge. In...
4.
Watanabe K, Toya T, Toyota Y, Kobayashi Y, Usuba J, Hijikata Y, et al.
Chem Commun (Camb)
. 2025 Jan;
61(13):2822-2825.
PMID: 39838903
The synthesis and characterization of fused aromatic networks composed of zinc tetrapyrazinoporphyrazines are reported. The steric repulsion of bulky substituents induced the formation of three-dimensional structures. Thus-obtained insoluble polymers adsorbed...
5.
Onodera Y, Ishiguro T, Uozumi R, Isono T, Nishida T, Kobayashi Y, et al.
Intern Med
. 2025 Jan;
PMID: 39756876
Objective Community-acquired pneumonia is an acute infectious disease with potentialy life-threatening consequences. Because invasive mechanical ventilation (IMV) requires the attention of many medical staff, early risk prediction at the time...
6.
Yoshioka D, de la Perrelle J, Dolan A, Goh Z, Kee T, Kobayashi Y
J Phys Chem Lett
. 2024 Dec;
15(50):12370-12375.
PMID: 39652421
The photoinduced ligand desorption from nanocrystal (NC) surfaces plays a critical role in the diverse functionalities of NCs. However, this reaction is inherently complex because photophysical and photochemical reactions are...
7.
Isono T, Kojima A, Nishida T, Kobayashi Y, Ishiguro T, Takaku Y, et al.
Intern Med
. 2024 Nov;
64(3):367-374.
PMID: 39566990
Objective Thymus and activation-regulated chemokine (TARC) can predict severe disease in patients with coronavirus disease 2019 (COVID-19). However, no reports have addressed the predictive value of TARC with the widespread...
8.
Kanemura A, Morisada T, Momomura M, Asano F, Shibuya H, Matsumoto H, et al.
Case Rep Obstet Gynecol
. 2024 Oct;
2024:1907965.
PMID: 39473877
In this case, a 66-year-old female patient presented with the chief complaint of abdominal distention. Computed tomography and magnetic resonance imaging revealed no enlarged ovaries or obvious primary lesions; however,...
9.
Kobayashi Y, Ishiguro T, Kagiyama N, Sumi M, Takayanagi N
J Clin Med
. 2024 Oct;
13(20).
PMID: 39458197
Pulmonary diseases are common in patients with thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA). Although high prevalences of chronic obstructive pulmonary disease and lung cancer (LC) are known,...
10.
Hasegawa K, Takahashi S, Ushijima K, Okadome M, Yonemori K, Yokota H, et al.
Cancer Med
. 2024 Sep;
13(18):e70236.
PMID: 39325020
Background: In the phase 3 EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 study, cemiplimab significantly improved overall survival (OS) versus chemotherapy for patients with recurrent or metastatic cervical cancer who progressed after first-line platinum-based chemotherapy....